You are here



Networking takes over business

Networking is becoming more and more strategic (and highly valued) in all biotechnology, pharmaceutical and medical technology companies. Although establishing and maintaining professional contacts has always been important, networking has changed the way companies structure marketing and business management.


By Isabel Muntané 

In both Spanish and Catalan, we often use English words without even realizing it and these naturally become part of our professional and personal communication. However many times we are unaware of the exact meaning of these words. Networking is a good example of this: an English word that is commonly used in the business world.

But what is networking? As often happens with these terms, networking has many applications and in the workplace can mean teamwork or creating a network. Dr. Jordi Robert-Ribes, a professional speaker on Networking&Business, gives a very clear definition: “Creating and maintaining mutually beneficial professional relationships, either online (via Internet) or offline (face-to-face).” And the mutually beneficial nature of these relationships is key to understanding and consolidating networking as, according to Robert-Ribes, if we aim to apply it correctly in our companies, “we must look beyond the potential profit to be obtained and think also of what we can contribute to our network of contacts.”

Networking has three distinct but interconnected stages, which Jordi Robert-Ribes compares graphically to building a road. “First, we must survey the land, as this is key. Then comes the time to build and this stage of building trust is key. Finally, maintaining contact. We must be clear that this maintenance goes beyond a simple Christmas card. We must contribute value to our contacts.”




Most companies that use networking start the process at international fairs because they believe this is essential to their business activity. Intelligent Pharma, created in 2007 in the Barcelona Science Park, has professionals devoted exclusively to this action.


Oryzon, a benchmark among biotechnology firms in Spain, recently signed an agreement with a pharmaceutical company from New Zealand to develop a product to diagnose bladder cancer thanks to networking.